A brief 7-day estimate of alcohol consumption for use in smoking cessation clinical trials.

A brief 7-day estimate of alcohol consumption for use in smoking cessation clinical trials.
复制标题

用于戒烟临床试验的 7 天饮酒量简短估计。

DOI:
10.1016/j.addbeh.2008.07.007
复制
发表时间:
2008
影响因子:
4.4
通讯作者:
O'Malley,StephanieS
O'Malley,StephanieS
中科院分区:
医学2区
文献类型:
--
作者:
Toll,BenjaminA;Leeman,RobertF;McKee,SherryA;O'Malley,StephanieS

文献摘要

被引文献

相似文献

越来越多的证据表明,饮酒和吸烟复发之间的关联表明,重要的是要衡量酒精的使用在戒烟研究。然而,大多数研究没有这样做,通常是因为这些评估需要额外的时间负担。来自两项戒烟临床试验的参与者(N=634)的数据用于检查基线和治疗期间短期和长期监测大量时间轴随访(TLFB)饮酒指标之间的关系。在基线饮酒数据的短(7和14天)和长(30和60天)时间窗口之间发现了高相关性。在戒烟治疗期间,饮酒数据的短时间窗(治疗的最后7天)和长时间窗(整个治疗期)之间的相关性也大多在高范围内。虽然总的禁欲显着高估了较短的时间窗口,对于那些谁被错误分类,禁欲的天数百分比高,大量饮酒的天数百分比和每天饮酒的数量在较长的时间内较低。因此,在基线时对7天内饮酒的简要估计可能提供对戒酒天数百分比、重度饮酒天数百分比和每个饮酒日的饮酒次数的代表性评估。然而,为了估计基线和治疗期间的禁欲情况,可能需要更全面的监测期。
Accruing evidence of an association between drinking and smoking relapse suggests that it is important to measure alcohol use in smoking cessation studies. However, most studies do not do so, often because of the extra time burden required for these assessments. Data from participants (N=634) in two smoking cessation clinical trials were used to examine the relationship between short and longer periods of monitoring for a number of Timeline Followback (TLFB) drinking metrics at baseline and during treatment. High intercorrelations were found between short (7 and 14 days) and longer (30 and 60 days) time windows for baseline drinking data. Intercorrelations between short (last 7 days of treatment) and longer (entire treatment period) time windows of drinking data during the smoking cessation treatment period were also mostly in the high range. Although total abstinence was significantly overestimated with shorter time windows, for those who were misclassified, percentage of days abstinent was high and percentage of heavy drinking days and number of drinks per drinking day were low during the longer period. Thus, a brief estimate of alcohol use over 7 days at baseline is likely to provide a representative assessment of percentage of days abstinent, percentage of heavy drinking days, and number of drinks per drinking day. To estimate abstinence at baseline and during treatment, however, a more comprehensive period of monitoring may be required.